Oscar Health

OSCR

Market cap $4.59B

Overview Fund Activity

17.77 USD

-0.16

0.89%

At close Updated Sep 17, 4:00 PM EDT

Pre-market

After hours

17.98

+0.21

1.18%

1 day

-0.89%

5 days

-11.02%

1 month

6.73%

3 months

10.3%

6 months

32.12%

Year to date

31.14%

1 year

-18.97%

5 years

-48.94%

10 years

-48.94%

About: Oscar Health Inc is a health insurance company. The company provides various insurance plans for individuals, families, and employees. Also, the company provides virtual care, doctor support, scheduling appointments, and other related services. The company provides plans in the Medicare Advantage program to adults who are age 65 and older and eligible for traditional Medicare but who instead select coverage through a private market plan.

Employees: 2,400

Healthcare Healthcare Plans

0

Funds holding %

of 7,463 funds

0

Analysts bullish %

of 5 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

78% more first-time investments, than exits

New positions opened: 91 | Existing positions closed: 51

47% more capital invested

Capital invested by funds: $2.45B [Q1] → $3.61B (+$1.16B) [Q2]

43% more funds holding in top 10

Funds holding in top 10: 7 [Q1] → 10 (+3) [Q2]

31% more repeat investments, than reductions

Existing positions increased: 117 | Existing positions reduced: 89

13% more funds holding

Funds holding: 286 [Q1] → 324 (+38) [Q2]

9% more call options, than puts

Call options by funds: $257M | Put options by funds: $236M

9.94% less ownership

Funds ownership: 86.77% [Q1] → 76.83% (-9.94%) [Q2]

See Fund Rankings

Research analyst outlook

5 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$10

44% downside

Avg. target

$11.8

34% downside

High target

$14

21% downside

5 analyst ratings

0 positive

0%

2 neutral

40%

3 negative

60%

Piper Sandler Jessica Tassan	$13	Neutral Maintained	14 Aug 2025
Baird Michael Ha	$14	Neutral Downgraded	25 Jul 2025
Barclays Andrew Mok	$11	Underweight Maintained	23 Jul 2025
UBS Jonathan Yong	$11	Sell Downgraded	15 Jul 2025
Wells Fargo Stephen Baxter	$10	Underweight Downgraded	11 Jul 2025

See Analyst Rankings

Financial journalist opinion

Based on 11 articles about OSCR published over the past 30 days

Oscar Health: The Market Is Mispricing This Disruptor

Oscar Health stock is up 21% since my strong buy rating, outperforming the S&P 500's 4% return. Membership surpassed 2.0 million in June 2025, growing 28% year-over-year compared to just 13% ACA market growth. Expansion remains the primary catalyst, with coverage in 18 states and 446 counties, targeting 150 new metros by 2027.

Oscar Health: The Market Is Mispricing This Disruptor

What's Going On With Oscar Health Stock On Tuesday?

Healthcare tech firm Oscar Health Inc. OSCR priced its offering of $355 million of 2.25% convertible senior subordinated notes due 2030 in a private offering.

What's Going On With Oscar Health Stock On Tuesday?

Oscar Health Prices Upsized $355,000,000 Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR) today announced the pricing of its offering of $355,000,000 aggregate principal amount of 2.25% convertible senior subordinated notes due 2030 (the “notes”) in a private offering (the “Offering”) to qualified investors.1 The offering size was increased from the previously announced offering size of $350,000,000 aggregate principal amount of notes. The issuance and sale of the notes are scheduled to settle on September 18, 2025.

Oscar Health Prices Upsized $355,000,000 Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market

Zacks Investment Research

Oscar Health, Inc. (OSCR) Stock Falls Amid Market Uptick: What Investors Need to Know

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $18.73, marking a -3.1% move from the previous day.

Oscar Health, Inc. (OSCR) Stock Falls Amid Market Uptick: What Investors Need to Know

Oscar Health Launches Proposed Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR) today announced its intention to offer, subject to market and other conditions, $350,000,000 aggregate principal amount of convertible senior subordinated notes due 2030 (the “notes”) in a private offering (the “Offering”) to qualified investors.1 Oscar also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first iss.

Oscar Health Launches Proposed Convertible Senior Subordinated Notes Offering to Scale Long-Term Growth and Consumer and Employer Adoption of the Individual Market

The Motley Fool

Is Oscar Health Stock a Buy Right Now?

In this video, I will cover the recent updates regarding Oscar Health (OSCR -1.65%). Watch the short video to learn more, consider subscribing, and click the special offer link below.

Is Oscar Health Stock a Buy Right Now?

The Motley Fool

Best Healthcare Stocks: UnitedHealth Stock vs. Oscar Health

Healthcare stocks have been trading at attractive valuations following the industry's significant share price declines.

Best Healthcare Stocks: UnitedHealth Stock vs. Oscar Health

Oscar Health: The Industry Is Having A Cold But 2026 Looks To Be Much Better

Oscar Health is poised for a strong rebound in 2026 after a challenging 2025, driven by significant premium rate increases and improved pricing discipline. The company's technology-driven platform and +Oscar business create a competitive edge, supporting both internal growth and external revenue streams. Despite industry headwinds and legislative uncertainty, Oscar's low valuation, strong revenue growth, and founder-led governance offer an attractive risk/reward profile.

Oscar Health: The Industry Is Having A Cold But 2026 Looks To Be Much Better

Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire

Wall Street's most crowded shorts are starting to look like powder kegs. Rocket Companies Inc RKT, Oscar Health Inc OSCR, and Hims & Hers Health Inc HIMS are sitting at the top of the market's short-interest leaderboard, each with more than a quarter of their float sold short.

Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire

The Motley Fool

Should Investors Buy Oscar Health Stock?

Oscar Health (OSCR 0.98%) reported a jump in its costs to serve customers, bringing down its profitability.

Should Investors Buy Oscar Health Stock?

See News Rankings

Charts implemented using Lightweight Charts™